GLP1R and metabolic dysfunction-associated steatotic liver disease: Drugs used to treat T2DM with effects on NAFLD histology are thiazolidinediones (TZDs), glucagon-like peptide-1 receptor agonist (GLP-1 RA) and sodium-glucose cotransporter- (SGLT)-2 inhibitors (117, 203–205).